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Original Research Article 
Phytochemical profile and anti-tumor activity evaluation of the crude extract, 
essential oil and d-limonene from Citrus aurantium  L. against Ehrlich carcinoma. 
ABSTRACT 
Plant based drugs have been a solution in the search for more cost-effective and less 
harmful drugs for the treatment of neoplasia. Citrus aurantium L. (Rutaceae) is 
abundant in Brazil and d-limonene, a monoterpene used in the prevention and treatment 
of neoplasia, was identified as a major compound in the oil of this specie. This study 
aims to evaluate the anti-tumor activity of the crude extract, essential oil and d-limonene 
from Citrus aurantium L. (Rutaceae) against Ehrlich carcinoma, as well as the 
phytochemical evaluation of the essential oil and d-limonene. This is a randomized non-
clinical trial in which were used adult male mice (Balb-C). The animals were divided 
into four groups (n=6). All groups were inoculated with the Ehrlich tumor and then 
received the treatment (control, crude extract, essential oil and d-limonene) by oral route 
daily (X day treatment). The chemical constitution of the essential oil (obtained by 
hydro-distillation) and d-limonene was analyzed by gas chromatography attached to 
mass spectrometry (GC-MS). A hemogram was performed at the end of the experiment. 
Animals treated with the essential oil has shown no significant difference compared to 
the group treated with d-limonene. The group treated with crude extract had a growth 
inhibition close to the essential oil and d-limonene groups. It´s concluded that the 
essential oil and the crude extract of Citrus aurantium, L. (Rutaceae) can become 
therapeutic agents because of their anti-tumor activity with no toxicity to the blood cells 
and have low cost of production. Further studies are necessary, so they can be used in 
the treatment of neoplasia in humans. The chromatographic and spectrometric analyzes 
indicated the presence of other components in smaller amounts in the essential oil, 
which suggests that they could have a synergic activity to the d-limonene.  
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spectrometry. 
INTRODUCTION 
Plant based drugs have been a solution in the search for more cost-effective and 
less harmful drugs for the treatment of neoplasia. Several species originated medicines 
such as Taxus brevifolia (Paclitaxel
®
), Catharanthus roseus (vincristine and 
vimblastine), Curcuma longa (curcumin) and others. Citrus aurantium L. (Rutaceae), 
commonly known as orange, is a traditional fruit abundant in Brazil. From it peels, d-
limonene, a chemical marker was identified. This compound is a monoterpene used in 
the prevention and treatment of neoplasia. Limonene is a cheap, effective and promising 
compound with a broad spectrum of anticancer activity
1
. Moreover, the anticancer of 
orange essential oil and other compounds present, were investigated in cancer cell lines 
A549 (human lung) and 22RV-1 (prostate). The essential oil, comprised mainly with D-
limonene (74.6%) has shown a positive effect on the proliferation and inhibition of 
these cells line
2
.  
The constituents of the essential oils are originated by the mevalonic acid 
pathway. Preferentially, monoterpenes and sesquiterpenes are synthetized, which are 
hydrocarbons with the general formula (C5H8)n, known as isoprene. These are 
oxygenated compounds derived from hydrocarbons including alcohols, esters, 
aldehydes, ethers, phenols, ketones and oxides. There are several activities reported for 
  
this class, like as antibacterial, antifungal, antiviral and antioxidant properties
3
. In 
Brazil, the genus Citrus is one of the most important commercial fruit crops. The genus 
includes several species of oranges, tangerines, limes, mandarins, grapefruit and 
lemons. 
 Limonene (1-methyl-4-isopropyl-cyclohexene) consists of two isoprene units, 
that comprises more than 90% of citrus essential oil and it exists in many fruits and 
vegetables. Although, the anticancer activity of d-limonene has identified nearly two 
decades ago, it has recently attracted much more attention in translational medicine
4
.
 
 
D-limonene comprises more than 90% of the orange peel oil. It has shown to have 
chemopreventive activity against lung, liver, skin and forestomach cancers
5
. It has been 
demonstrated to induce apoptosis on tumor cells
6
. Moreover, perillyl alcohol, a 
hydroxylated limonene analog, has present chemopreventive activity against liver, 
pancreas, mammary gland and colon cancer in rodent
7
.  
The principal metabolites of limonene are (+)- and (−)-trans–carveol, a product of 
6-hydroxylation) and (+)- and (−)-perillyl alcohol, a product of 7-hydroxylation by 
CYP2C9 and CYP2C19 cytochromes in human liver microsomes
8
.The enantiomers 
of perillyl alcohol have been investigated for their pharmacological activities as dietary 
chemotherapeutic agents. They are viewed as novel therapeutic options in some 
CNS neoplasms and other solid tumors, particularly for the treatment of gliomas
9
.
 
The cytotoxic activities of perillyl alcohol and limonene metabolites are likely due to 
their  antiangiogenic  activities,  hyperthermia  inducing effects as well as 
negative apoptosis regulation and Ras pathways
10
. 
The study of orange oil, limonene and extracts has shown an interesting effect of 
these compounds upon cancer and several illnesses associated to antioxidant activity. 
Some enzymes activity was analyzed and the increase of glutathione-S- transferase 
(GST), glutathione content (GSH), and lipid peroxidation (LPO) has been demonstrated, 
supporting the antitumor effect of these compounds
11
.  
Considering the exposed above, it is important to study all possibilities associated 
to orange oil and cancer, once this is a cheap product, with high production in Brazil 
and well seeing all over the world as a promising agent in this filed.  
The present study aims to evaluate the anti-tumor activity of the crude extract, 
essential oil and d-limonene against Ehrlich carcinoma as well as the phytochemical 
analyses of the essential oil and d-limonene of C. aurantium and the comparison among 
these products. 
 
MATERIALS AND METHODS  
Essential oil gas chromatography/ mass spectrometry (GC-MS) 
GC analysis was carried out using an Shimadzu gas chromatograph GC-2012 
Plus equipped with flame ionization detector and an DB-5 (fused silica) column (30 m× 
0.25 mm I.D., film thickness 0.25 μm) and split ratio, 1:25. The GC settings were as 
follows: initial oven temperature was held at 40 °C for 1 min, rising to 250 °C at 5 
°C/min. The injector temperature was maintained at 250 °C. The detector temperature 
was at 230 °C. The carrier gas used was Helium at a flow rate of 1,37 ml/min. GC-MS 
was performed on Agilent Technology 5973 mass selective detector connected with an 
Shimadzu GC-2012 Plus gas chromatograph. The oil and d-limonene of C. 
  
aurantium was analyzed using an DB-5 (Fused silica) with the same column and 
temperature programmed as above. The MS operated from 10 to 200 eV ionization 
energy. Quantitative data were obtained from the electronic integration of the Flame 
Ionization Detector (FID) peak areas
12
. 
Animals 
Mice (Balb-C, 20–28 g) of 8 weeks of age were used for the experiment and 
were kept in polyacrylic cages. The animals were grouped in three per cage. The 
animals were maintained in standard laboratory conditions with controlled temperature 
(20 + 2 C
o
), relative humidity (55 + 5%) and with the dark/light cycle (12/12 h). Food 
(standard dry pellet diet) and water were provided ad libitum. Mice were obtained from 
the Central Biotery of FMABC. All the described procedures were reviewed and 
approved by Federal University of São Paulo Animal Ethics Committee (CEUA # 
415527). 
Ehrlich tumor model  
EAC cells were collected by sterile disposable syringe from donor mice (Balb-
C) of 20–28 g body weight and suspended in sterile isotonic saline. The viability of the 
cells was 99% as judged by trypan blue exclusion assay. To asses a solid mass of 
Ehrlich tumor, a fixed number of viable cells 0.2 mL EAC cells containing 
5 × 10
5
 cells/mouse were inoculated intraperitoneally and left for 28 days to allow 
tumor to grow. 
Treatment schedule  
Seven days after the inoculation of the Ehrlich cells, the treatments have started. 
The animals (n=24) were divided into four groups, each containing six mice. They 
received their treatment orally by gavage daily, as follow: 
Group I (control group): treated with 0.3 ml of 0.9% saline solution. 
Group II: Treated with 0.3% of crude extract of C. aurantium diluted in 0.50 ml of 0.9% 
saline solution. 
Group III: animals treated with 0.3 ml of essential oil from C. aurantium. 
Group IV: animals treated with 0.3 ml of d-limonene diluted in 0.50 ml of 0.9% saline 
solution. 
In order to measure the tumor growth, the animals were measured weekly with a 
digital pachymeter. 
At the end of the 28 days of experiment, mice were sacrificed by cervical 
decapitation. Blood was collected and storage in EDTA tubes for hemogram analyses. 
The tumor mass were weighed, storaged and frozen in liquid nitrogen. 
Statistical analysis  
All data are presented as the mean ± standard error of mean (SEM).  Shapiro-
Wilk test was used for data distribution. For the correlation regarding body size and 
body weight between moments in the groups was used the Spearman test. The 
difference regarding body weight and size in the initial and final moments among 
groups was analyzed using the Kruskall-Wallis test was used.  Experiment was 
performed using Stat 11.0 software. Results were considered significant 
when P < 0.0513.  
RESULTS AND DISCUSSION 
Natural products have a long history of use in traditional medicines and their 
activities against different diseases have been the focus of many basic and clinical 
researches in past few decades. The essential oils, volatile liquid containing aroma 
  
compound from plants, are known as active ingredients in the herbal medicine. Perillyl 
alcohol (POH) is usually available through dietary sources and is being explored for 
its cancer chemoprevention, tumor growth suppression, and regression
14
. Citrus peels 
are the waste product of juice manufacturing industries and have been considered as a 
critical problem for environmental green ecology policies for years. One of the most 
well-known approaches to overcome this problem is transformation of these 
monoterpene by the use of specific strains of bacteria or yeasts. Limonene (1-methyl-4-
isopropyl-cyclohexene) is a monoterpene, as other monoterpenes consists of two 
isoprene units, that comprises more than 90% of citrus essential oil and it exists in many 
fruits and vegetables. Although, the anticancer activity of d-limonene has identified 
nearly two decades ago, it has recently attracted much more attention in translational 
medicine
4
. 
Chemical constituents were evaluated in terms of qualitative and quantitative 
analyses by gas chromatography/mass spectrometry. Fifty-four components were 
identified in the essential oil and 44 in the extracts. In all cultivars, the main component 
was D-limonene (73.9 - 97%). Discrete percentages of linalool, geraniol and nerol were 
also found. Cluster analysis based on essential oils composition showed a certain degree 
of affinity between cultivars of the same type. The antimicrobial activity was 
investigated against three micro-organisms (Staphylococcus aureus, Listeria 
monocytogens and Pseudomonas aeruginosa). 'Sanguinello' and 'Solarino Moro' 
essential oils were significantly active against L. monocytogenes, while 'Valencia' 
hexanic extract against all the tested micro-organisms was not
15
. 
Characteristic mass spectra with many diagnostic ions were obtained from 
the extract analysis, allowing a fast and reliable identification of these species. Tandem 
mass spectrometry (MS/MS) was employed to confirm the identity of specific 
metabolites. HPTLC/DESI-MS imaging is a relatively fast, versatile, and efficient 
technique for natural product analysis, since many more ions are observed than with the 
direct infusion ESI-MS. The MS/MS technique provided information about the 
component structures, revealing the presence of important bioactive components.   The 
application of DESI-MS imaging may contribute to the improvement identification and 
characterization of pharmacologically active compounds in phytochemistry
16
. 
The chromatographic analyses of the essential oil of C. aurantium have shown 
14 components: β-pinene, β-mircene, 3-carene, d-limonene, α-pinene, cis-β-ocimene, γ-
terpinene, β-linalol, α-terpineol, nerill acetate, linalil acetate, lavandulol acetate, 
geraniol acetate and α-bisabolene. The major compound identified in the oil was D-
limonene and β-pinene. The chromatographic profile and the spectrometric results 
where the components were identified using the GC-Solution software are below. 
  
 
Figure 1. C. aurantium Essential oil chromatographic profile 
 
Figure 2. β-pinene mass spectrum. 
 
Figure 3. D-limonene mass spectrum. 
 
 
The chemical characterization of d-limonene from C. aurantium using GC-MS 
has made possible to properly identify the component. The chromatographic profile and 
mass spectrum obtained using the GC Solution software is below. 
Figure 4. D-limonene chromatographic profile. 
 
  
 
Figure 5. D-limonene mass spectrum. 
 
 
Contemporary nutrition regime has focused the attention of the researchers on 
phytochemicals enriched spices to mitigate various oncological threats. Numerous 
chemopreventive strategies against malignancy have been developed considering the 
anticancer perspectives of allied nutraceutical constituents. Current evidences have 
proven an inverse association of spices with that of oncological incidences. The high 
antioxidant activity of spices derived bioactives triggers the free radicals scavenging 
ability at cellular level thereby alleviating various metabolic syndromes. Promising 
compounds including curcumin and curcuminoids (turmeric), limonene (cardamom), 
allicin, allyl isothiocyanate (garlic), cinnamic aldehyde, 2-hydroxycinnamaldehyde and 
eugenol (cinnamon), gingerol, zingiberone, zingiberene (ginger), dipropyle disulfides 
and quercetin (onion), piperidine piperine, limonene, α- and β-pinene (black pepper), 
crocetin, crocin and safranal (saffron) have been identified as chemopreventing agents 
against various malignancies
17
. 
D-limonene is considered to have fairly low toxicity. It has been tested for 
carcinogenicity in mice and rats. Although initial results showed d-limonene increased 
the incidence of renal tubular tumors in male rats, female rats and mice in both genders 
showed no evidence of any tumor. Subsequent studies have determined how these 
tumors occur and established that d-limonene does not pose a mutagenic, carcinogenic, 
or nephrotoxic risk to humans. In humans, d-limonene has demonstrated low toxicity 
after single and repeated dosing for up to one year
18
. As a cholesterol solvent, d-
limonene has been used clinically to dissolve cholesterol-containing gallstones. Because 
of its gastric acid neutralizing effect and its support of normal peristalsis, it has also 
been used for relief of heartburn and gastroesophageal reflux (GERD). D-limonene has 
well-established chemopreventive activity against many types of cancer. Evidence from 
a phase I clinical trial demonstrated a partial response in a patient with breast cancer and 
stable disease for more than six months in three patients with colorectal cancer
19
. 
Table 1. Lifespam and weighs of the animals at the begginig and end of the 
experiment. 
  ANIMAL lifespam 
Initial 
weight 
Final 
weight  
C
O
N
T
R
O
L
 
C1 28 26 28 
C2 28 24 28 
C3 28 24 24 
C4 28 24 26 
C5 28 22 26 
C6 28 22 28 
C
R U D
E
 
E
X
T
R A C
T
 
C1 28 28 30 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The animals were measured at the beginning and at the end of the experiment in 
order to identify possible abnormalities. To analyze the data distribution, we used the 
Shapiro-Wilk test. To analyze the correlation of weight between moments in the groups, 
the Spearman correlation test was used. The Kruskall-Wallis test was used to analyze 
the difference between weights in the initial and final moments between the groups. The 
level of confidence was 5% and the software used was Stata11.0. No significant 
differences were observed in all analyzes on body weight.  
The animals were weighed on analytical balance at the beginning and at the end of 
the experiment in order to identify possible abnormalities. The data distribution was 
analyzed using the Shapiro-Wilk test. The correlation of weight between moments in 
the groups was analyzed using the Spearman correlation test was used. The Kruskall-
Wallis test was used to analyze the difference between weights in the initial and final 
moments between the groups. The level of confidence was 5% and the software used 
was Stata11.0. No significant differences were observed in all analyzes on body weight. 
Table 2. Body measures in centimeters. 
C2 28 26 20 
C3 28 26 28 
C4 28 26 28 
C5 28 24 28 
C6 28 24 30 
E
S
S
E
N
T
IA
L
 O
IL
 
C1 28 24 26 
C2 28 24 26 
C3 28 24 26 
C4 28 26 28 
C5 28 28 30 
C6 28 26 20 
D
-L
IM
O
N
E
N
E
 C1 28 28 32 
C2 28 24 26 
C3 28 26 30 
C4 28 26 28 
C5 28 24 26 
C6 28 26 28 
  ANIMAL 
Lifespam 
(days) Initial Final 
C
O
N
T
R
O
L
 
C1 28 9.53 17.78 
C2 28 8.90 13.85 
C3 28 13.12 20.35 
C4 28 8.89 7.27 
C5 28 6.87 10.07 
C6 28 8.59 10.69 
C
R
U
D
E
 
E
X
T
R
A
C
T
 
C1 28 8.63 9.34 
C2 28 19.22 22.24 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the hemogram, the red 
and white blood series were evaluated, and the statistical analysis was performed for 
each blood parameter. 
The cells identified with (-) indicate loss of the animal during the experiment, 
making it impossible to collect blood. 
In general, lymphocytes, neutrophils, leukocytes and monocytes had higher levels 
in those in the control group than those in the treatment groups. However, when 
analyzing the data by the Analysis of Variance (ANOVA) and then by the comparison 
test of Dunnett averages, it was not possible to observe, with 95% confidence, statistical 
difference between the groups tested. 
The Neutrophil / Lymphocyte Ratio (RLL) was evaluated and we could verify 
that, on average, the RLL of the control group is higher than that of the treatment 
groups, and that the ratio of the group that received extract is higher than that of the 
group receiving d-limonene. However, this difference was not considered statistically 
significant by ANOVA statistical methods followed by Dunnet's means comparison test 
at 95% confidence level. 
 
Table 3. Hemogram performed after euthanasia. 
  ANIMAL Lc Hc Hb Ht Plt Neut Linfo Mono 
C
O
N
T
R
O
L
 
C1 4.3 10.05 15.3 44.7 672 0.56 3.77 0.05 
C2 3.9 10.42 17.1 48.4 661 0.54 3.34 0.01 
C3 3.7 9.46 15.5 44.0 609 0.62 4.70 0.06 
C4 3.9 9.34 16.5 45.3 643 0.56 4.37 0.02 
C5 4.1 9.53 15.4 44.8 646 0.51 3.82 0.00 
C6 3.7 10.22 16.2 48.8 576 0.49 4.54 0.03 
C
R
U
D
E
 
E
X
T
R
A
C
T
 
C1 2.2 9.55 15.5 44.6 633 0.13 3.68 0.01 
C2 2.1 9.23 15.1 42.6 641 0.14 3.12 0.01 
C3 1.8 9.03 14.9 43.6 650 0.16 3.46 0.01 
C4 2.2 9.08 15.2 43.1 675 0.08 3.08 0.00 
C3 28 10.01 13.19 
C4 28 7.25 10.69 
C5 28 8.04 7.16 
C6 28 11.03 18.66 
E
S
S
E
N
T
IA
L
 O
IL
 
C1 28 7.05        -    
C2 28 8.16 10.34 
C3 28 5.78 6.95 
C4 28 16.88 22.68 
C5 28 4.75 13.57 
C6 28 21.93 21.505 
D
-L
IM
O
N
E
N
E
 C1 28 17.44 15.26 
C2 28 10.61 12.62 
C3 28 11.59 18.56 
C4 28 9.76 7.44 
C5 28 11.01 11.37 
C6 28 11.17 5.35 
  
C5 2.3 9.96 15.8 46.0 689 0.11 3.43 0.01 
C6 2.4 9.31 15.0 43.5 672 0.29 3.31 0.04 
E
S
S
E
N
T
IA
L
 O
IL
 
C1 1.8 9.41 15.8 44.4 689 0.14 2.26 0.00 
C2 2.1 9.85 15.4 44.9 719 0.10 2.01 0.00 
C3 2.4 9.80 15.6 45.8 693 0.11 2.24 0.00 
C4 2.3 9,74 15.2 43,9 698 0.14 2.33 0.01 
C5 2.7 8.93 14.7 42.7 657 0.18 2.32 0.03 
C6 2.4 9.29 14.9 44.1 693 0.17 2.48 0.02 
D
-L
IM
O
N
E
N
E
 C1 1.9 9,12 14.9 45.6 684 0.14 2.66 0.02 
C2 1.9 9.71 14.6 45.7 644 0.13 2.72 0.02 
C3 2.5 10.00 15.2 46.0 659 0.19 3.02 0.04 
C4 2.3 9.32 15.6 44.7 599 0.18 2.85 0.01 
C5 2.1 10.29 16.1 47.5 703 0.17 2.51 0.00 
C6 3.8 9.12 15.4 45.4 617 0.14 2.63 0.01 
Lc (leukocytes); Hc (red blood cells); Hb (hemoglobin); Ht (hematocrit); Plt (platelets); 
Neut (neutrophils); Lymphocytes and Mono (monocytes). 
 
 
 
 
 
 
 
Figure 6 – Inhibitory effect of crude extract, essential oil and d-limonene of C. 
aurantium against Ehrlich ascites carcinoma. Tumor weight in grams. 
Citrus bergamia (A.K.A. bergamot) has shown the potential to increase 
autophagy triggered by serum starvation and rapamycin. These findings indicate that the 
underlying mechanism is mTOR independent. In the other hand it did not affect the 
ULK1 and p70(S6K) phosphorylation, two downstream targets of mTOR. Moreover, 
the active major constituents for these effects, d-limonene and linalyl acetate, were also 
tested. The results have demonstrated that D-limonene rapidly increases LC3II and 
reduces p62 levels
20
. D-limonene epoxide had been tested for analgesic and anti-
inflammatory activities. It has inhibited both the release and activity of inflammatory 
mediators, decreasing vascular permeability and neutrophils migration. In the analgesic 
assays, it has displayed systemic and peripheral analgesic-dependent effects of the 
opioid system
21
.  
D-limonene has suppressed the viability of LS174T cells, resulting in a apoptotic 
cell death. It activates caspase-3 and -9 and PARP cleavage. Moreover, an increase in 
Bax protein and cytosol cytochrome c from mitochondria and a decrease in bcl-2 
protein were observed following treatment with d-limonene. Also, D-limonene 
decreased the levels of p-Akt, p-Akt and p-GSK-3β. These results suggest that D-
limonene induces apoptosis via the mitochondrial death and the suppression of the 
PI3K/Akt pathway
22
. The essential oil of Citrus sinensis inhibited colon cancer cells 
proliferation and induced apoptosis. Immunoblotting of colon cancer cells dose-
dependent induction of Bax/Bcl2 and inhibition of vascular endothelial growth factor 
     CONTROL           CRUDE EXTRACT          ESSENTIAL OIL         D-LIMONENE 
  
(VEGF). The antiangiogenic activity of this oil was also confirmed by inhibition of in 
vitro tube formation in human umbilical vein endothelial cells
23
.  
D-limonene has been demonstrated to exert antiproliferative effects on a 
lymphoma cell, increasing the nitric oxide levels by inducing cell apoptosis or through 
H2O2 production and ERK pathway activation at low concentrations. In high 
concentrations, it has inhibited the farnesylation of proteins and O2
-
 production
24
.  
The tumor growth was evaluated measuring the tumor weight in an analytical 
scale. The survival analysis was performed after the death of the animals. The control 
group has presented tumors weighing 2.89 + 0.34 g. All treated groups were 
significantly different from the control group (P < 0.05). The treatment with crude 
extract (0.61 + 0.14 g) was effective in reducing the tumor compared to the control.  
Furthermore, the groups treated with the essential oil (rich in limonene) have presented 
a significant difference from the control group but not among them. The treatment with 
D-limonene has shown the best result, with a weigh about 0.19 + 0.09 g. 
Considering the data above, the use results present in this study are in agreement 
with the literature about D-limonene and its potential as an anticancer drug or precursor 
(like limonene epoxide). This compound shows several mechanistic approach, related 
both to enzyme or genetic regulation, with high potential of obtention and no 
environment degradation since it is a waste product from orange crops and low cost. 
 
 
 
 
 
 
 
CONCLUSIONS 
It has been concluded that the essential oil and the crude extract of Citrus 
aurantium, L. (Rutaceae) can become therapeutic agents because they have anti-tumor 
activity with no toxicity to the blood cells and have low cost of production. Moreover, 
the use of D-limonene as a precursor for new medicines using semi synthetic 
approaches. The chromatographic and spectrometric analyzes indicated the presence of 
other components in smaller amounts in the essential oil, what suggests that they could 
have a synergic activity to the d-limonene. Further studies are necessary, so they can be 
used in the treatment of neoplasia in humans. 
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